Wilmington Trust’s Novartis NVS Stock Holding History

Wilmington Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$17.5M	Sell	215,753 -773	-0.4%	-$60.8K	0.29%	65
2014 Q1	$16.5M	Sell	216,526 -15,344	-7%	-$1.12M	0.28%	64
2013 Q4	$16.7M	Buy	231,870 +5,425	+2%	+$377K	0.28%	67
2013 Q3	$15.6M	Buy	226,445 +817	+0.4%	+$54.1K	0.27%	66
2013 Q2	$14.3M	Buy	+225,628	New	+$14.7M	0.29%	69

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wilmington Trust's NVS Position: Q2 2014 in Review

Wilmington Trust reduced its Novartis (NVS) stake by 0.36% in Q2 2014, selling an estimated $60.8K and leaving 215,753 shares worth $17.5M. The position accounts for 0.29% of the portfolio, ranked #65.

Wilmington Trust first reported a position in NVS in Q2 2013 and has held it in 5 quarters since. 848 funds tracked by Wall St. Rank hold NVS as of Q2 2014.

Wilmington Trust held 215,753 shares of Novartis worth $17.5M as of Q2 2014.
Wilmington Trust sold 773 Novartis shares in Q2 2014, an estimated $60.8K.
Novartis made up 0.29% of Wilmington Trust's portfolio in Q2 2014, its #65 holding.
Wilmington Trust first reported a position in Novartis in Q2 2013 and has held it in 5 quarters since.
848 funds tracked by Wall St. Rank held Novartis as of Q2 2014.

Based on Wilmington Trust's 13F filing for Q2 2014, filed 13 Aug 2014.